Fondée en 1994, CRISTALENS est une société de distribution de dispositifs médicaux pour la chirurgie de la cataracte. En 2006, elle a créé sa propre unité de fabrication d’implants intraoculaires hydrophiles et hydrophobes. En 2008, elle a mis au point une nouvelle matière première hydrophobe (phenoxy ethyl acrylate) qui autorise des micro-incisions inférieures à 2 mm. En 2013, cette invention lui a valu le prix de l’Innovation Industrielle.
En choisissant CRISTALENS, vous collaborez avec un laboratoire qui a une maitrise totale de son métier : de la fabrication de la matière première jusqu’au packaging et dont les trois mots clés sont :
CORPORATE
VIDEO
CRISTALENS AND
PATIENT SAFETY
CRISTALENS makes every effort to ensure optimum protection for the patient.
- CRISTALENS only works with ISO- certified suppliers that are respected in the ophthalmic industry.
- Its production unit offers clean rooms which are more efficient than standards requirements
- CRISTALENS is NF EN ISO 13485 certified . All our intraocular lenses are ce_0459
CRISTALENS AND
INNOVATION
CRISTALENS received in 2013 Research and Innovation Prize for the creation of its new hydrophobic material associated with its monofocal and toric micro-incisions lenses.
By integrating doctors in chemistry and optics, engineers in biomaterials and optical into its research and development team, and by collaborating with the largest French universities, CRISTALENS prepares the future implantable devices with complex optic.
CRISTALENS AND
PRODUCTION
No operation is outsourced.
CRISTALENS has made the choice to control its whole production line from manufacturing its own hydrophobic material to the packaging.
We use only latest-generation equipment connected to automation systems.
CRISTALENS AND
DISTRIBUTION
CRISTALENS received in 2013 Research and Innovation Prize for the creation of its new hydrophobic material associated with its monofocal and toric micro-incisions lenses.
By integrating doctors in chemistry and optics, engineers in biomaterials and optical into its research and development team, and by collaborating with the largest French universities, CRISTALENS prepares the future implantable devices with complex optic.